Cullinan Therapeutics (CGEM) Shares Repurchased (2020)
Historic Shares Repurchased for Cullinan Therapeutics (CGEM) over the last 1 years, with Q4 2020 value amounting to $6.4 million.
- Cullinan Therapeutics' Shares Repurchased changed N/A to $6.4 million in Q4 2020 from the same period last year, while for Dec 2020 it was $6.6 million, marking a year-over-year change of. This contributed to the annual value of $6.6 million for FY2020, which is N/A changed from last year.
- Per Cullinan Therapeutics' latest filing, its Shares Repurchased stood at $6.4 million for Q4 2020.
- In the past 5 years, Cullinan Therapeutics' Shares Repurchased ranged from a high of $6.4 million in Q4 2020 and a low of $213000.0 during Q1 2020